Detalhe da pesquisa
1.
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(3): 219-229, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065058
2.
Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes.
Mol Cancer Ther
; 17(12): 2575-2585, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266802
3.
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
Cancer Res
; 68(24): 10247-56, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074893